You are here: Geisinger Medical
Laboratories > Test
Catalog
Geisinger Medical Laboratories Test Catalog
NEWBORN TYPE AND SCREEN (FOR PATIENTS 4 MONTHS AND YOUNGER) |
||
Geisinger Epic Procedure Code: LAB3332
Geisinger Epic ID: 121942
|
||
SPECIMEN COLLECTION |
||
Specimen type: |
Whole blood | |
Preferred collection container: |
||
Alternate Collection Container: |
6 mL pink-top K2 EDTA tube
|
|
Specimen required: |
2 mL or 3 full EDTA microcollection tubes whole blood | |
Special notes: |
Add-on testing is not permitted. Specimen must be labeled with patient's first and last name, medical record number or some unique other identifier (e.g.,billing number, NOT date of birth). Date of collection and phlebotomist identification (full name or tech ID) must be available. Second samples are not required on patients less than 4 months of age. Newborn type and screens are valid until one of the following criteria is met: 1. Patient reaches 4 months of age 2. Patient is discharged.
Antibody-positive specimens will be worked up to the extent necessary to identify the antibody. Geisinger Health System workflow is to order type and screen followed by a prepare and transfuse order in Epic if blood products are needed. |
|
| SPECIMEN PROCESSING |
||
Specimen processing instructions: |
Do not centrifuge or aliquot. | |
Transport temperature: |
Preferred specimen: Room temperature (less than 24 hours). If greater than 24 hours, specimen must be stored and transported at 2-8° C. | |
Specimen stability: |
3 days for testing. | |
Rejection criteria: |
Incorrect collection tube. Incomplete label ID (see collection notes). | |
TEST DETAILS |
||
CPT code(s): |
86900, 86850, 86901 | |
| Note: The billing party has sole responsibility for CPT coding. Any questions regarding coding should be directed to the payer being billed. The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only. | ||
Methodology: |
RBC agglutination and/or gel column technology |
|
Synonyms: |
||
Clinical significance: |
Type and screen battery must be performed to provide compatible blood. "Type" includes ABO and Rh typing of the patient's red blood cells. "Screen" includes a red blood cell antibody screen, which can detect common clinically significant antibodies to red blood cells. | |
Doctoral Director(s:) |
Randin Nelson MD | |
| Review Date: | 10/21/2022 | |